Biocompatibility and bioactive potential of an experimental tricalcium silicate-based cement in comparison with Bio-C repair and MTA Repair HP materials. 2023

Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
Department of Restorative Dentistry, São Paulo State University (UNESP), Araraquara, Brazil.

OBJECTIVE To evaluate the tissue reaction of a tricalcium silicate-based repair material associated with 30% calcium tungstate (TCS + CaWO4 ) in comparison to Bio-C Repair (Bio-C; Angelus) and to MTA Repair HP (MTA HP; Angelus). METHODS Polyethylene tubes filled with one of the materials or left empty (control group, CG) were implanted into the subcutaneous tissues of rats for 7, 15, 30 and 60 days (n = 32/group). The capsule thickness, number of inflammatory cells, collagen content, interleukin-6 (IL-6), osteocalcin (OCN), von Kossa reaction and analysis under polarized light were evaluated. The data were subjected to generalized linear models for repeated measures, except the OCN. OCN data were submitted to Kruskal-Wallis and Dunn's post hoc test and Friedman followed by Nemenyi's test at significance level of 5%. RESULTS At all time points, significant differences in the number of inflammatory cells were not observed between TCS + CaWO4 and Bio-C, whereas, at 15, 30 and 60 days, no significant difference was detected between TCS + CaWO4 and MTA HP. At all periods, significant differences were not detected in the number of fibroblasts in TCS + CaWO4 versus MTA HP, and, at 60 days, no significant difference was demonstrated between these groups and CG. Significant differences in the immunoexpression of IL-6 were not detected amongst bioceramic materials at all periods. From 7 to 60 days, significant reduction in the number of inflammatory cells, number of IL-6-immunopositive cells and in the capsule thickness was accompanied by significant increase in the collagen in all groups. OCN-immunolabelled cells, von Kossa-positive structures and amorphous calcite deposits were observed around all materials, whereas, in the CG, these structures were not seen. CONCLUSIONS These findings indicate that the experimental material (TCS + CaWO4 ) is biocompatible and has a bioactive potential, similar to the MTA HP and Bio-C Repair, and suggest its use as a root repair material.

UI MeSH Term Description Entries
D008422 Materials Testing The testing of materials and devices, especially those used for PROSTHESES AND IMPLANTS; SUTURES; TISSUE ADHESIVES; etc., for hardness, strength, durability, safety, efficacy, and biocompatibility. Biocompatibility Testing,Biocompatible Materials Testing,Hemocompatibility Testing,Testing, Biocompatible Materials,Testing, Hemocompatible Materials,Hemocompatibility Testings,Hemocompatible Materials Testing,Materials Testing, Biocompatible,Materials Testing, Hemocompatible,Testing, Biocompatibility,Testing, Hemocompatibility,Testing, Materials,Testings, Biocompatibility
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003738 Dental Cements Substances used to bond COMPOSITE RESINS to DENTAL ENAMEL and DENTIN. These bonding or luting agents are used in restorative dentistry, ROOT CANAL THERAPY; PROSTHODONTICS; and ORTHODONTICS. Dental Adhesives,Luting Agents,Orthodontic Adhesives,Cement, Dental,Cements, Dental,Dental Cement,Adhesive, Dental,Adhesive, Orthodontic,Adhesives, Dental,Adhesives, Orthodontic,Dental Adhesive,Luting Agent,Orthodontic Adhesive
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005899 Glass Ionomer Cements A polymer obtained by reacting polyacrylic acid with a special anion-leachable glass (alumino-silicate). The resulting cement is more durable and tougher than others in that the materials comprising the polymer backbone do not leach out. Glass Ionomer Cement,Glass Polyalkenoate Cement,Polyalkenoate Cement,Polyalkenoate Cements,Glass Polyalkenoate Cements,Glass-Ionomer Cement,Cement, Glass Ionomer,Cement, Glass Polyalkenoate,Cement, Glass-Ionomer,Cement, Polyalkenoate,Cements, Glass Ionomer,Cements, Glass Polyalkenoate,Cements, Glass-Ionomer,Cements, Polyalkenoate,Glass-Ionomer Cements,Ionomer Cement, Glass,Polyalkenoate Cement, Glass
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D012387 Root Canal Filling Materials Materials placed inside a root canal for the purpose of obturating or sealing it. The materials may be gutta-percha, silver cones, paste mixtures, or other substances. (Dorland, 28th ed, p631 & Boucher's Clinical Dental Terminology, 4th ed, p187) Root Canal Filling Material,Root Canal Sealants,Sealants, Root Canal,Canal Sealant, Root,Canal Sealants, Root,Root Canal Sealant,Sealant, Root Canal
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
December 2017, International endodontic journal,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
August 2021, Materials (Basel, Switzerland),
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
September 2021, International endodontic journal,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
April 2018, Journal of applied oral science : revista FOB,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
January 2012, Journal of biomedical materials research. Part B, Applied biomaterials,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
November 2020, Materials science & engineering. C, Materials for biological applications,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
January 2023, Brazilian dental journal,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
March 2024, International endodontic journal,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
May 2019, International endodontic journal,
Marcela Borsatto Queiroz, and Rafaela N H Inada, and José Leandro de Abreu Jampani, and Juliane Maria Guerreiro-Tanomaru, and Estela Sasso-Cerri, and Mário Tanomaru-Filho, and Paulo Sérgio Cerri
August 2019, Journal of biomedical materials research. Part B, Applied biomaterials,
Copied contents to your clipboard!